Minerva Neurosciences to Present at Jefferies 2016 London Healthcare Conference on November 17, 2016
November 10, 2016 08:30 ET
|
Minerva Neurosciences, Inc.
WALTHAM, Mass., Nov. 10, 2016 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central...